Meclizine and Paleness - a phase IV clinical study of FDA data

Summary:

Paleness is reported as a side effect among people who take Meclizine (meclizine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Lasix, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Paleness when taking Meclizine. It is created by eHealthMe based on reports of 22,264 people who have side effects when taking Meclizine from the FDA, and is updated regularly.

What is Meclizine?

Meclizine has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 23,116 Meclizine users. Check the latest studies of Meclizine.

What is Paleness?

Paleness (unusual lightness of skin colour) is found to be associated with 1,566 drugs and 2,116 conditions by eHealthMe. Check the latest studies of Paleness.

On Jul, 19, 2026

22,264 people reported to have side effects when taking Meclizine.
Among them, 36 people (0.16%) have Paleness.

Among these 36 people:

How long have people been on Meclizine when they have Paleness? *

What is the gender of people who have Paleness when taking Meclizine? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Paleness when taking Meclizine? *

What are other drugs people take besides Meclizine? *

What are other side effects people have besides Paleness? *

Diarrhea: 15 people, 41.67%
Weakness: 13 people, 36.11%
Constipation: 9 people, 25.00%
Fatigue (feeling of tiredness): 9 people, 25.00%
Joint Pain: 9 people, 25.00%
Nausea And Vomiting: 9 people, 25.00%
Headache (pain in head): 8 people, 22.22%
Gait Disturbance: 8 people, 22.22%
Dyspnea (difficult or laboured breathing): 8 people, 22.22%
Oedema Peripheral (superficial swelling): 8 people, 22.22%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 16.67%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 4 people, 11.11%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 11.11%
High Blood Cholesterol: 3 people, 8.33%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 8.33%
Cystitis Interstitial (unknown cause characterized by bladder pain): 2 people, 5.56%
Cough: 2 people, 5.56%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 5.56%
Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Meclizine and have Paleness?

- Check whether Paleness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Meclizine:

Meclizine (23,116 reports)

Paleness treatments and more:

Paleness (34,670 reports)

Browse all side effects of Meclizine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paleness:

Paleness (1,566 drugs)

Browse all the conditions that are associated with Paleness:

Paleness (2,116 conditions)

Related publications that referenced our studies

Hassan JK, "POTENTIAL POSITIVE EFFECT OF ORAL PYRIDOXINE ALONE AND IN COMBINATION WITH MECLIZINE ON CIGARETTES SMOKING DURING TENDAYS’TRIAL", IJPSR, 2015 Jan .
Hassan JK, "POTENTIAL POSITIVE EFFECT OF ORAL PYRIDOXINE ALONE AND IN COMBINATION WITH MECLIZINE ON CIGARETTES SMOKING DURING TENDAYS’TRIAL", IJPSR, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on meclizine hydrochloride (the active ingredients of Meclizine) and Meclizine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.